157 related articles for article (PubMed ID: 36702105)
1. Focal Therapy for Renal Cancer: Comparative Trends in the USA and Germany from 2006 to 2020 and Analysis of the German Health Care Landscape.
Flegar L; Thoduka SG; Mahnken AH; Figiel J; Heers H; Aksoy C; Eisenmenger N; Groeben C; Huber J; Zacharis A
Urol Int; 2023; 107(4):396-405. PubMed ID: 36702105
[TBL] [Abstract][Full Text] [Related]
2. Alternative- and focal therapy trends for prostate cancer: a total population analysis of in-patient treatments in Germany from 2006 to 2019.
Flegar L; Zacharis A; Aksoy C; Heers H; Derigs M; Eisenmenger N; Borkowetz A; Groeben C; Huber J
World J Urol; 2022 Jul; 40(7):1645-1652. PubMed ID: 35562598
[TBL] [Abstract][Full Text] [Related]
3. Incidence of multiple sporadic renal cell carcinomas in patients referred for renal radiofrequency ablation: implications for imaging follow-up.
Beland MD; Wolf FJ; Grand DJ; Dupuy DE; Mayo-Smith WW
AJR Am J Roentgenol; 2011 Sep; 197(3):671-5. PubMed ID: 21862810
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
5. Treatment Trends and Long-Term Survival Associated with Cryotherapy and Partial Nephrectomy for Small Renal Masses in the National Cancer Database Using Propensity Score Matching.
Kitley W; Sulek J; Sundaram C; Bahler CD
J Endourol; 2019 May; 33(5):408-414. PubMed ID: 30808185
[No Abstract] [Full Text] [Related]
6. Percutaneous Radiofrequency Ablation Versus Robotic-Assisted Partial Nephrectomy for the Treatment of Small Renal Cell Carcinoma.
Pantelidou M; Challacombe B; McGrath A; Brown M; Ilyas S; Katsanos K; Adam A
Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1595-1603. PubMed ID: 27435582
[TBL] [Abstract][Full Text] [Related]
7. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
[TBL] [Abstract][Full Text] [Related]
8. RFA versus robotic partial nephrectomy for T1a renal cell carcinoma: a propensity score-matched comparison of mid-term outcome.
Park BK; Gong IH; Kang MY; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Seo SI
Eur Radiol; 2018 Jul; 28(7):2979-2985. PubMed ID: 29426988
[TBL] [Abstract][Full Text] [Related]
9. Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis.
Choueiri TK; Schutz FA; Hevelone ND; Nguyen PL; Lipsitz SR; Williams SB; Silverman SG; Hu JC
Urology; 2011 Jul; 78(1):93-8. PubMed ID: 21550636
[TBL] [Abstract][Full Text] [Related]
10. Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005-2010: a population-based study from the national Swedish kidney cancer register.
Thorstenson A; Bergman M; Scherman-Plogell AH; Hosseinnia S; Ljungberg B; Adolfsson J; Lundstam S
Scand J Urol; 2014 Jun; 48(3):231-8. PubMed ID: 24666102
[TBL] [Abstract][Full Text] [Related]
11. Association of type of renal surgery and access to robotic technology for kidney cancer: results from a population-based cohort.
Kardos SV; Gross CP; Shah ND; Schulam PG; Trinh QD; Smaldone MC; Sun M; Weight CJ; Sammon J; Han LC; Kim SP
BJU Int; 2014 Oct; 114(4):549-54. PubMed ID: 24571281
[TBL] [Abstract][Full Text] [Related]
12. Local ablation vs partial nephrectomy in T1N0M0 renal cell carcinoma: An inverse probability of treatment weighting analysis.
Shi L; He Y; Liu C; Qian X; Wang Z
Cancer Med; 2020 Nov; 9(21):7988-8003. PubMed ID: 32888392
[TBL] [Abstract][Full Text] [Related]
13. Trend of Surgical Treatment of Localized Renal Cell Carcinoma.
Jabaji RB; Fischer H; Kern T; Chien GW
Perm J; 2019; 23():18-108. PubMed ID: 30624203
[TBL] [Abstract][Full Text] [Related]
14. Trends in the surgical management of localized renal masses: thermal ablation, partial and radical nephrectomy in the USA, 1998-2008.
Woldrich JM; Palazzi K; Stroup SP; Sur RL; Parsons JK; Chang D; Derweesh IH
BJU Int; 2013 Jun; 111(8):1261-8. PubMed ID: 23470140
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic Body Radiotherapy for Stage I Renal Cell Carcinoma: National Treatment Trends and Outcomes Compared to Partial Nephrectomy and Thermal Ablation.
Uhlig A; Uhlig J; Trojan L; Kim HS
J Vasc Interv Radiol; 2020 Apr; 31(4):564-571. PubMed ID: 32127324
[TBL] [Abstract][Full Text] [Related]
16. Comparative Effectiveness of Thermal Ablation, Surgical Resection, and Active Surveillance for T1a Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked Population Study.
Xing M; Kokabi N; Zhang D; Ludwig JM; Kim HS
Radiology; 2018 Jul; 288(1):81-90. PubMed ID: 29737950
[TBL] [Abstract][Full Text] [Related]
17. Comparison among cryoablation, radiofrequency ablation, and partial nephrectomy for renal cell carcinomas sized smaller than 2 cm or sized 2-4 cm: A population-based study.
Yan S; Yang W; Zhu CM; Yan PM; Wang ZC
Medicine (Baltimore); 2019 May; 98(21):e15610. PubMed ID: 31124938
[TBL] [Abstract][Full Text] [Related]
18. Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (≤4 cm): an analysis of the SEER database.
Daugherty M; Bratslavsky G
Urol Oncol; 2014 Jul; 32(5):549-54. PubMed ID: 24495447
[TBL] [Abstract][Full Text] [Related]
19. Focal therapy versus robot-assisted partial nephrectomy in the management of clinical T1 renal masses: A systematic review and meta-analysis.
Yoon YE; Lee HH; Kim KH; Park SY; Moon HS; Lee SR; Hong YK; Park DS; Kim DK
Medicine (Baltimore); 2018 Nov; 97(45):e13102. PubMed ID: 30407321
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant autologous tumour cell-lysate vaccine versus no adjuvant treatment in patients with M0 renal cell carcinoma after radical nephrectomy: 3-year interim analysis of a German multicentre phase-III trial.
Doehn Ch; Richter A; Lehmacher W; Jocham D
Folia Biol (Praha); 2003; 49(2):69-73. PubMed ID: 12779015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
